Skip to main content

United Arab Emirates · Drugs and Pharmaceuticals

Anifrolumab 300 mg/2 ml (150 mg/ml) Intravenous Solution

Buyer not disclosed

Expired

Tender summary

Anifrolumab 300 mg/2 ml (150 mg/ml) Intravenous Solution. Published by a buyer not disclosed in this summary in United Arab Emirates. Category: Drugs and Pharmaceuticals.

Buyer
Not disclosed
Country
United Arab Emirates
Category
Drugs and Pharmaceuticals
Closing date
16 September 2026
Updated
14 September 2026